{"code":200,"success":true,"data":{"id":"2056576445113757697","createUser":"2000475995285549057","createDept":"1909880195533090818","createTime":"2026-05-19 11:23:29","updateUser":"2048974693212418050","updateTime":"2026-06-22 13:40:05","status":1,"isDeleted":0,"tenantId":"000000","registrantId":"2000475995218440193","registrantType":2,"registrantCode":"91430100MA4L2PGH3T","registrantName":"长沙都正生物科技股份有限公司","registrantSnapshootId":"2000475995402989570","registrationTime":"2026-05-19 11:24:08","dataRegistCode":"DA.CN.43.01.20260519.QRFB4ENUSQ","dataRegistName":"1956年至今-全球-生物医药-氧化三甲胺疾病关联与影响因素-数据报告","dataType":"4","dataOtherType":"","industry":"M7310","industryBigcode":"73","regionalScope":"1","regionalScopeArea":"00","timeDomainRangeStart":"1956-01-01","timeDomainRangeEnd":"2026-04-30","dataContentIntroduction":"收集和纳入了超过 3500 篇文献及专利的核心要素，经专家治理得到的数据资源包括三大核心数据：①TMAO 与疾病关联数据：包含 1500 余条 TMAO 水平与疾病关联的临床研究数据，覆盖心血管、代谢、肾脏、肿瘤等多类疾病；②TMAO 影响因素数据：包含 1800 余条饮食、肠道菌群、代谢酶等影响 TMAO 生成的研究数据，涵盖膳食成分、益生菌、生活方式等关键因素；③TMAO 检测方法数据：包含 120 余条 TMAO 定量检测技术与方法学数据，涉及色谱、质谱、免疫检测等主流技术。为确保数据质量与可靠性，该数据库建立了标准化数据治理与更新机制，每月迭代更新，从数据来源权威性、研究设计严谨性、结果可重复性等维度严格质控，显著提升数据的可信度与实用价值。","dataSource":"3","dataSourcesInfo":"{\"sourceType\":\"2\",\"descDocument\":\"[{\\\"url\\\":\\\"2068889322042486785\\\",\\\"name\\\":\\\"公开收集情况说明书.pdf\\\"}]\",\"commitment\":\"[{\\\"url\\\":\\\"2054380257241264129\\\",\\\"name\\\":\\\"承诺书（TMAO）-都正生物20260513.pdf\\\"}]\",\"appraisalType\":\"1\",\"appraisalReport\":\"[{\\\"url\\\":\\\"2054378431410401282\\\",\\\"name\\\":\\\"数据产品合规评估法律意见书（都正）.pdf\\\"}]\"}","dataScale":"3400 + 条数据","dataOrder":"6.28","dataOrderUnit":"5","dataStructure":"1","dataOtherStructure":"","dataFormat":"2","dataOtherFormat":"","updateFrequency":"8","updateOtherFrequency":"","ableScene":"1）疾病易感性研究：通过分析 TMAO 水平与疾病关联，识别代谢风险标志物，支持疾病预防和早期筛查。如 TMAO 升高与心血管疾病、糖尿病、慢性肾病、血栓风险的关联。2）疾病风险分层与预后评估：基于 TMAO 浓度及动态变化，对高危人群进行风险分层，辅助判断疾病进展与预后，指导干预时机与强度。3）饮食 / 肠道菌群干预指导：研究饮食、肠道菌群、代谢酶对 TMAO 生成的影响，指导低 TMAO 饮食、益生菌 / 益生元干预，降低代谢性疾病风险。4）药物研发与药效评估：筛选调控 TMAO 合成 / 代谢的靶点（如 FMO3、肠道菌群），开发降低 TMAO 的创新药物 / 功能食品；用于临床试验中评估药物对 TMAO 水平及相关代谢通路的影响。5）群体流行病学研究：探索不同地区、人群、生活方式下 TMAO 分布特征，解析代谢差异、疾病地域分布及饮食进化影响。6）个性化健康管理与精准营养：基于个体 TMAO 水平、饮食结构、肠道菌群特征，制定个性化饮食、营养补充与生活方式干预方案，实现精准健康管理。","ableSceneSample":"使用该数据报告分析TMAO水平与疾病关联，识别代谢风险标志物，支持疾病预防和诊断。如TMAO 升高与心血管疾病、2 型糖尿病、慢性肾病等风险的关联。","ableSceneLimit":"不允许再次转售。","involvePersonalData":0,"involvePersonalDataInfo":"","involveImportData":0,"involveImportDataInfo":"","involveCoreData":0,"involveCoreDataInfo":"","involvePublicData":0,"involvePublicDataDesc":"","involveCriticalInformation":0,"involveCriticalInformationDesc":"","involveMajorInformation":0,"involveMajorInformationDesc":"","involveDataExport":0,"involveDataExportDesc":"","complianceSupplementaryInformation":"","depositMethod":"1","depositDescription":"自行存证数据源文件,数据采集、加工、治理过程文档,权属声明、承诺书、授权协议,数据安全合规、隐私合规说明,登记申报的全套申报材料。","depositProofDocument":"[{\"url\":\"2054750154379030530\",\"name\":\"TMAO存证证明.pdf\"}]","dataFields":"","dataSample":"[{\"url\":\"2054131018837848065\",\"name\":\"TMAO数据库-数据样例.csv\"}]","dataFingerprint":"","dataWatermark":"","dataRightType":"1,2,3","dataRightDescription":"","dataRights":"2056576610549690369,2056576610549690370,2056576610553884674","sourcePlatform":"01","dataUnifiedCode":"","dataRegistMode":2,"createBizType":1,"createApplyId":"2056576445151506433","snapshootId":"2056986046745341953","deptName":"湖南省大数据交易所","platformName":"","industryName":"自然科学研究和试验发展","regionalScopeName":"国际级","regionalScopeAreaName":"全国","timeDomainRange":"1956-01-01至2026-04-30","registrantInfo":{},"dataFieldList":[],"dataRightList":[{"id":"2056576610549690369","dataRegistId":"2056576445113757697","rightType":1,"holdStatus":1,"storageConfigScreenshot":"","proofDocument":"[{\"url\":\"2056576060131176450\",\"name\":\"TMAO数据持有证明文件.pdf\"},{\"url\":\"2068891110753759233\",\"name\":\"存储信息.png\"},{\"url\":\"2068930708951330818\",\"name\":\"TMAO数据集.pdf\"},{\"url\":\"2068931989904355329\",\"name\":\"付费数据购买凭证.pdf\"}]","startTime":"2023-10-08","endTime":"长期","rightLimit":"本单位持有TMAO与影响因素和疾病关联数据报告，其权利受限于以下情形： 1、本数据集含 PubMed 检索及 Sci-Hub 获取的文献全文，申请人仅对自身完成的文献全文结构化拆解、字段抽取、TMAO-影响因素/疾病关联标注、数据清洗规整、数据报告架构编排等独创性加工成果享有持有权；所有原始文献全文的著作权、版权归属原作者及期刊出版商，本产权登记不涉及原始文献权属转移； 2、数据报告不对外公开原始全文源文件，仅限内部受控环境存储、管理与维护。","rightRemark":"","status":1},{"id":"2056576610549690370","dataRegistId":"2056576445113757697","rightType":2,"holdStatus":null,"storageConfigScreenshot":"","proofDocument":"[{\"url\":\"2068931745560981505\",\"name\":\"实质性差别的说明材料.pdf\"}]","startTime":"2023-10-08","endTime":"长期","rightLimit":"本单位对TMAO与影响因素和疾病关联数据报告享有使用权，其使用受限于： 1、用于TMAO与影响因素、疾病关联科学研究、学术分析、科研模型训练、课题研发等场景； 2、 使用过程中仅可引用研究结论与关联分析结果，不得大篇幅复制、转载、汇编原始文献全文内容对外发布。","rightRemark":"","status":1},{"id":"2056576610553884674","dataRegistId":"2056576445113757697","rightType":3,"holdStatus":null,"storageConfigScreenshot":"","proofDocument":"[{\"url\":\"2056576273096962050\",\"name\":\"TMAO与数据建设流程图.pdf\"}]","startTime":"2023-10-08","endTime":"长期","rightLimit":"本单位对所持有的持有TMAO与影响因素和疾病关联数据集拥有经营权，其行使受限于以下条件： 1、数据对外提供方式包括许可使用、合作开发等，但不得以原始数据形式直接出售； 2、许可协议须明确约定数据用途、期限、费用及违约责任，确保交易合法合规； 3、收益分配遵循“谁投入谁受益”的原则，若涉及多个数据来源方，则按贡献比例分配； 4、在经营过程中须保障数据安全，防止泄露、滥用，不得损害公众利益； 5、对加工形成的衍生数据，明确其权属归属于本单位，但使用时仍需遵守原数据来源方的授权范围。","rightRemark":"","status":1}],"dataAttachList":[],"reviewOrderItemList":[{"id":"2056576610612604929","bizItemId":"1986345398074777601","reviewItemId":"1986345398074777601","reviewItemName":"合规审查","reviewItemDesc":"","reviewMethod":2,"proofFile":"[{\"url\":\"2054752025650982913\",\"name\":\"数据产品合规评估法律意见书（都正）.pdf\"}]","reviewReport":"","payableAmount":null,"selected":true},{"id":"2056576610616799233","bizItemId":"1996464645286719490","reviewItemId":"1996464645286719490","reviewItemName":"登记服务","reviewItemDesc":"","reviewMethod":3,"proofFile":"","reviewReport":"","payableAmount":null,"selected":true}],"certificateCode":"SJ4302026050009","validityPeriod":"2026-05-28至2031-05-28"},"msg":"操作成功"}